USP7 is frequently overexpressed in NB cell lines and patient tumors and has been associated with aggressive tumor behavior and poor clinical outcomes, further suggesting that USP7 inhibitors are likely to be effective against NB cells and tumors. Here, USP7 is linked to neoplasm.